JBK Lab has opened the first Selmed USA store in Atlanta, USA.


JBK Lab (CEO Jang Bong-geun) announced on the 11th that it has signed a contract with Eli Pharmacy (Chief Pharmacist Jennifer Hong) located in Atlanta, USA, as the first Selmed sales pharmacy and will officially sell Selmed's natural nutraceutical products such as Siaplex and Eupaflex in the US market.

In front of Eli Pharmacy, Selmed's first store in the United States, JBKLAB CEO Jang Bong-geun (left) and Chief Pharmacist Jennifer Hong (right) are taking a commemorative photo. Photo by JBKLAB

In front of Eli Pharmacy, Selmed's first store in the United States, JBKLAB CEO Jang Bong-geun (left) and Chief Pharmacist Jennifer Hong (right) are taking a commemorative photo. Photo by JBKLAB

View original image

JBK Lab is entering the US market with products such as Siaplex F, which helps antioxidant activity with a patented anthocyanin and fucoidan complex, and Eupaflex, made from non-oxidized Noyufa oil. The products exported to the US comply with the US FDA guidelines for local sales and will be introduced through nutritional therapy consultations by expert pharmacists, just like in Korea.


The partner pharmacy, Eli Pharmacy, which has partnered with JBK Lab, is operated by a passionate young team of pharmacists targeting not only the mainstream American society but also various ethnicities and generations. Jennifer Hong, who founded the hospital management solution company Eli Medical Solution in 2018 and provided consulting to many hospitals, serves as the chief pharmacist.


Eli Pharmacy plans to introduce various Selmed nutraceutical products based on the theory of "cell correction nutritional therapy," which corrects damaged genes and cell membranes with nutrients. "Cell correction nutritional therapy" started as an attempt to enhance immunity and natural healing power through the intake of natural, naturally derived nutrients to manage the rapidly increasing chronic diseases. Nutraceutical, a portmanteau of nutrition and pharmaceutical, refers to functional foods with effects comparable to pharmaceuticals. JBK Lab plans to provide various support, including education, to ensure that nutraceutical products based on cell correction nutritional therapy are well distributed in the US market.


Regarding the background of the contract between the two companies, Jennifer Hong, chief pharmacist of Eli Pharmacy, said, "The Selmed business model, where expert pharmacists sell natural nutraceutical products through consultations with customers, will be a driving force for revitalizing the local independent small pharmacy market in the US." She added, "Especially, the popularity of health functional foods based on plant-derived ingredients, including herbs, is high in the US, so Selmed products using natural plant-based ingredients will have strong competitiveness."


JBK Lab CEO Jang Bong-geun said, "We are pleased to introduce Selmed products made from natural ingredients to the US market," and added, "We plan to launch all Selmed products in the US market by the first half of next year." He pledged, "We will actively challenge product research and development as well as overseas market expansion to become the representative K-nutraceutical brand in the global market."



Meanwhile, according to market research firm IBISWorld, the domestic market size of health functional foods in the US last year was $38.15 billion (about 48 trillion KRW), and it is expected to continue growing steadily in line with the self-medication trend. Products that enhance physical abilities, such as multivitamins containing antioxidants targeting the elderly who are highly interested in health management, and dietary supplements that help improve heart health and digestive functions, are steadily gaining popularity.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing